- Drug Pipelines
- January 2022
- 30 Pages
Global
From €471EUR$500USD£403GBP
Urolosin is a class of drugs used to treat prostate cancer. These drugs are typically used in combination with other treatments such as radiation therapy and hormone therapy. Urolosin works by blocking the production of testosterone, which is a hormone that can stimulate the growth of prostate cancer cells. Urolosin can also reduce the size of the prostate and reduce the risk of metastasis. Side effects of Urolosin include hot flashes, fatigue, and decreased libido.
Urolosin is a relatively new class of drugs and is still being studied for its effectiveness in treating prostate cancer. It is becoming increasingly popular as an alternative to traditional treatments such as surgery and radiation therapy.
Some companies in the Urolosin market include Astellas Pharma, Bayer, and Pfizer. Show Less Read more